Skip to content

Azenta AZTA Continuing operations (in dollars per share)

Continuing operations (in dollars per share) at other companies

CryoPort, Inc. logo
CryoPort, Inc.CYRX
BioLife Solutions logo
BioLife SolutionsBLFS
Revvity logo
RevvityRVTY
NeoGenomics logo
NeoGenomicsNEO
Fortive logo
FortiveFTV

Other financials

Income statement

See full
Revenue$144.8M+1.0%
Gross profit$62.0M-1.2%
Operating income-$165.8M-811%
Net income-$160.8M-237%
EPS (diluted)-$3.49-236%

Balance sheet

See full
Cash & equivalents$125.2M
Total debt$55.7M
Total equity$1.6B-8.3%
Total assets$1.9B

Cash flow

See full
Operating cash flow$13.5M-6.2%
CapEx$7.4M-0.1%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.1B-16.3%
Enterprise value$1.03B
P/S1.8×-0.2×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-29.1%-80.7pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-10.7%-22.4pp
Debt / equity
Current ratio2.8×

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsPerBasicShare.

The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Azenta's continuing operations (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Azenta's continuing operations (in dollars per share)?
Azenta (AZTA) reported continuing operations (in dollars per share) of -$3.41 in Q1 2026.
How has Azenta's continuing operations (in dollars per share) changed year-over-year?
Azenta's continuing operations (in dollars per share) decreased by 693.0% year-over-year, from -$0.43 to -$3.41.